These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19706777)

  • 1. The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach.
    Basanta D; Strand DW; Lukner RB; Franco OE; Cliffel DE; Ayala GE; Hayward SW; Anderson AR
    Cancer Res; 2009 Sep; 69(17):7111-20. PubMed ID: 19706777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reactive stroma microenvironment and prostate cancer progression.
    Barron DA; Rowley DR
    Endocr Relat Cancer; 2012 Dec; 19(6):R187-204. PubMed ID: 22930558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
    Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
    Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.
    Lee C; Jia Z; Rahmatpanah F; Zhang Q; Zi X; McClelland M; Mercola D
    Biomed Res Int; 2014; 2014():502093. PubMed ID: 25089270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
    Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
    Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stroma.
    Carstens JL; Shahi P; Van Tsang S; Smith B; Creighton CJ; Zhang Y; Seamans A; Seethammagari M; Vedula I; Levitt JM; Ittmann MM; Rowley DR; Spencer DM
    Cancer Res; 2014 Jan; 74(2):609-20. PubMed ID: 24305876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
    O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
    Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
    Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
    Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for stromal heterogeneity in prostate tumorigenesis.
    Kiskowski MA; Jackson RS; Banerjee J; Li X; Kang M; Iturregui JM; Franco OE; Hayward SW; Bhowmick NA
    Cancer Res; 2011 May; 71(10):3459-70. PubMed ID: 21444670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What might a stromal response mean to prostate cancer progression?
    Rowley DR
    Cancer Metastasis Rev; 1998-1999; 17(4):411-9. PubMed ID: 10453285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.
    Verona EV; Elkahloun AG; Yang J; Bandyopadhyay A; Yeh IT; Sun LZ
    Cancer Res; 2007 Jun; 67(12):5737-46. PubMed ID: 17575140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER.
    Ahel J; Hudorović N; Vičić-Hudorović V; Nikles H
    Acta Clin Croat; 2019 Mar; 58(1):128-138. PubMed ID: 31363335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.
    Zhao FJ; Han BM; Yu SQ; Xia SJ
    Asian J Androl; 2009 Mar; 11(2):176-82. PubMed ID: 19122679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.